Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo

Benutzer: Gast

Titel:: Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Holzleitner, Nadine ; Günther, Thomas ; Beck, Roswitha ; Lapa, Constantin ; Wester, Hans-Jürgen
Stichworte:: Article ; cholecystokinin-2 receptor (CCK-2R) ; cholecystokinin-B receptor (CCK-BR) ; medullary thyroid cancer (MTC) ; minigastrin analogues ; radiohybrid ; rhCCK
Zeitschriftentitel:: Pharmaceuticals
Jahr:: 2022
Band / Volume:: 15
Heft / Issue:: 12
Volltext / DOI:: doi:10.3390/ph15121467
Verlag / Institution:: MDPI
E-ISSN:: 1424-8247
Publikationsdatum:: 25.11.2022
CC-Lizenz:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Vorkommen: